Publication | Closed Access

Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data

Amarcand2 Study DataAntifungal AgentAntifungal AgentsPatient SafetyClinical MycologyInfection ControlAntifungal De-escalationPost Hoc AnalysesMedicineClinical Microbiology